Beneficial ownership — 13D / 13G
87,387 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.
Coverage begins December 2024, when the SEC required these schedules to be filed as structured XML.
| Reporting person | Issuer | Schedule | % of class | Event date | Filed |
|---|---|---|---|---|---|
| Balyasny Asset Management L.P. | IRD Opus Genetics, Inc. | 13G/A | 7.18% | Mar 31, 2026 | 6mo |
| VAN ECK ASSOCIATES CORP | NXE NexGen Energy Ltd. | 13G | 5.13% | Mar 31, 2026 | 6mo |
| Harvey Partners, LLC | GLDD Great Lakes Dredge & Dock CORP | 13G/A | 0.9% | Mar 31, 2026 | 6mo |
| 683 Capital Management, LLC | MRSN Mersana Therapeutics, Inc. Common Stock | 13G/A | 0% | Mar 31, 2026 | 6mo |
| Nantahala Capital Management, LLC | VENU Venu Holding Corp | 13G | 6.59% | Mar 31, 2026 | 6mo |
| WELLINGTON MANAGEMENT GROUP LLP | BMRC Bank of Marin Bancorp | 13G/A | 3.9% | Mar 31, 2026 | 6mo |
| WuXi PharmaTech Healthcare Fund I L.P. | ADAG Adagene Inc. | 13G/A | 5.9% | Mar 31, 2026 | 6mo |
| ARMISTICE CAPITAL, LLC | BCYC Bicycle Therapeutics PLC | 13G/A | 6.75% | Mar 31, 2026 | 6mo |
| Polar Asset Management Partners Inc. | RIBB Ribbon Acquisition Corp. | 13G/A | 2.1% | Mar 31, 2026 | 6mo |
| METEORA CAPITAL, LLC | OAKU Oak Woods Acquisition Corp | 13G/A | 14.15% | Mar 31, 2026 | 6mo |
| Andreessen Horowitz Fund IV, L.P. | OMDA Omada Health, Inc. | 13G/A | 4.2% | Mar 31, 2026 | 6mo |
| CROSSLINK CAPITAL INC | CHYM Chime Financial, Inc. | 13G/A | 7.5% | Mar 31, 2026 | 6mo |
| Manulife Investment Management (US) LLC | EBMT Eagle Bancorp Montana, Inc. | 13G/A | 4.98% | Mar 31, 2026 | 6mo |
| RP Investment Advisors LP | ONCH 1RT Acquisition Corp. | 13G/A | 6.3% | Mar 31, 2026 | 6mo |
| D1 Capital Partners L.P. | FLS Flowserve Corp | 13G/A | 4.6% | Mar 31, 2026 | 6mo |
| Kynam Capital Management, LP | BNR Burning Rock Biotech Ltd | 13G/A | 13.97% | Mar 31, 2026 | 6mo |
| Balyasny Asset Management L.P. | TXNM Txnm Energy Inc | 13G | 6.97% | Mar 31, 2026 | 6mo |
| D. E. Shaw & Co., L.P. | LEU Centrus Energy Corp | 13G/A | 2% | Mar 31, 2026 | 6mo |
| JANUS HENDERSON GROUP PLC | LNTH Lantheus Holdings, Inc. | 13G/A | 7.4% | Mar 31, 2026 | 6mo |
| First Trust Capital Management L.P. | VNME Vendome Acquisition Corp I | 13G/A | 5.46% | Mar 31, 2026 | 6mo |
| Nantahala Capital Management, LLC | NDLS NOODLES & Co | 13G/A | 9.46% | Mar 31, 2026 | 6mo |
| WELLINGTON MANAGEMENT GROUP LLP | CARG CarGurus, Inc. | 13G/A | 7.3% | Mar 31, 2026 | 6mo |
| PRICE T ROWE ASSOCIATES INC /MD/ | PNR PENTAIR plc | 13G | 7% | Mar 31, 2026 | 6mo |
| EcoR1 Capital, LLC | VYGR Voyager Therapeutics, Inc. | 13G/A | 0% | Mar 31, 2026 | 6mo |
| T. Rowe Price Investment Management, Inc. | GSHD Goosehead Insurance, Inc. | 13G/A | 5% | Mar 31, 2026 | 6mo |
| PRICE T ROWE ASSOCIATES INC /MD/ | KNF Knife River Corp | 13G/A | 7.9% | Mar 31, 2026 | 6mo |
| PRICE T ROWE ASSOCIATES INC /MD/ | IE Ivanhoe Electric Inc. | 13G/A | 7.7% | Mar 31, 2026 | 6mo |
| David T. Lu | BHM Bluerock Homes Trust, Inc. | 13G/A | 6.1% | Mar 31, 2026 | 6mo |
| T. Rowe Price Investment Management, Inc. | DNLI Denali Therapeutics Inc. | 13G | 5.4% | Mar 31, 2026 | 6mo |
| Long Focus Capital Management, LLC | BCYC Bicycle Therapeutics PLC | 13G | 6.6% | Mar 31, 2026 | 6mo |
| EAGLE CAPITAL MANAGEMENT LLC | LEN Lennar Corp | 13G | 5.03% | Mar 31, 2026 | 6mo |
| Long Focus Capital Management, LLC | TLYS Tilly's, Inc. | 13G | 0% | Mar 31, 2026 | 6mo |
| Merus Global Investments, LLC | GFUZ General Fusion Group Ltd. | 13G/A | 8.6% | Mar 31, 2026 | 6mo |
| Pertento Partners LLP | PAX Patria Investments Ltd | 13G/A | 8% | Mar 31, 2026 | 6mo |
| Capital Ventures International | LAZRQ Luminar Technologies, Inc. | 13G/A | 9.9% | Mar 31, 2026 | 6mo |
| VAN ECK ASSOCIATES CORP | SGML Sigma Lithium Corp | 13G | 5.12% | Mar 31, 2026 | 6mo |
| Flagship Pioneering, LLC | GENB Generate Biomedicines, Inc. | 13G | 48.9% | Mar 31, 2026 | 6mo |
| Alyeska Investment Group, L.P. | VHUB VenHub Global, Inc. | 13G | 9.99% | Mar 31, 2026 | 6mo |
| J. Goldman & Co LP | DSAC Daedalus Special Acquisition Corp. | 13G/A | 4.87% | Mar 31, 2026 | 6mo |
| 683 Capital Management, LLC | MODD Modular Medical, Inc. | 13G/A | 4.67% | Mar 31, 2026 | 6mo |
| WELLINGTON MANAGEMENT GROUP LLP | HLIO Helios Technologies, Inc. | 13G/A | 3.9% | Mar 31, 2026 | 6mo |
| GMT Capital Corp | CINT CI&T Inc | 13G | 5.1% | Mar 31, 2026 | 6mo |
| Bellevue Group AG | CLDX Celldex Therapeutics, Inc. | 13G/A | 1.5% | Mar 31, 2026 | 6mo |
| Xiangmin Cui | UPB Upstream Bio, Inc. | 13G/A | 5% | Mar 31, 2026 | 6mo |
| Nantahala Capital Management, LLC | AVR Anteris Technologies Global Corp. | 13G/A | 6.28% | Mar 31, 2026 | 6mo |
| Westchester Capital Management, LLC | PLMK Plum Acquisition Corp. IV | 13G/A | 4.98% | Mar 31, 2026 | 6mo |
| Logos Global Management LP | TENX Tenax Therapeutics, Inc. | 13G/A | 3% | Mar 31, 2026 | 6mo |
| T. Rowe Price Investment Management, Inc. | BRCB Black Rock Coffee Bar, Inc. | 13G/A | 0% | Mar 31, 2026 | 6mo |
| Lingotto Investment Management LLP | SBSW Sibanye Stillwater Ltd | 13G/A | 5.32% | Mar 31, 2026 | 6mo |
| RTW INVESTMENTS, LP | REPL Replimune Group, Inc. | 13G/A | 8.9% | Mar 31, 2026 | 6mo |